Changing oral vaccine to inactivated polio vaccine might increase mortality

The Lancet

Volumn 387, Issue 10023, 2016, Pages 1054-1055

  Fish, Eleanor N ^a,b   Flanagan, Kate L ^c,d   Furman, David ^e,f   Klein, Sabra L ^g   Kollmann, Tobias R ^h   Jeppesen, Dorthe L ⁱ   Levy, Ofer ^j   Marchant, Arnaud ^k   Namachivayam, Siva ^l   Netea, Mihai G ^m   Plebanski, Magdalena ^c   Rowland Jones, Sarah L ⁿ   Selin, Liisa K ^o   Shann, Frank ^p   Whittle, Hilton C ^q  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ STENO DIABETES CENTER   (Denmark)

^j HARVARD MEDICAL SCHOOL   (United States)

^k UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^l ROYAL CHILDREN'S HOSPITAL   (Australia)

^m RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ UNIVERSITY OF OXFORD   (United Kingdom)

^o UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^p UNIVERSITY OF MELBOURNE   (Australia)

^q LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; INACTIVATED POLIO VACCINE; INACTIVATED VACCINE; LIVE VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG; VACCINE;

HUMAN; INFANT MORTALITY; LETTER; MORTALITY; POLIOMYELITIS; PRIORITY JOURNAL; DRUG SUBSTITUTION; FEMALE; MALE;

DRUG SUBSTITUTION; FEMALE; HUMANS; MALE; POLIOMYELITIS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL;

EID: 84961285320     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)00661-9     Document Type: Letter

References (5)

1. P Aaby, TR Kollmann, CS Benn Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges Nat Immunol 15 2014 895 899
2. JPT Higgins, K Soares-Weiser, A Reingold Systematic review of the non-specific effects of BCG, DTP and measles containing vaccines http://www.who.int/immunization/sage/meetings/2014/april/3-NSE-Epidemiology-review-Report-to-SAGE-14-Mar-FINAL.pdf 2014 (accessed April 24, 2015).
3. Vaccine-associated paralytic polio (VAPP) and vaccine-derived poliovirus (VDPV) Fact sheet http://www.who.int/immunization/diseases/poliomyelitis/endgame-objective2/oral-polio-vaccine/VAPPandcVDPVFactSheet-Feb2015.pdf February, 2015 (accessed Feb 17, 2016).
4. N Lund, A Andersen, AS Hansen et al. The effect of oral polio vaccine at birth on infant mortality: a randomized trial Clin Infect Dis 61 2015 1504 1511
5. P Aaby, ML Garly, J Nielsen et al. Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: observations from vaccination trials in Guinea-Bissau Pediatr Infect Dis J 26 2007 247 252